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AbsTrACT
Objective To determine whether apathy or depression 
predicts all- cause dementia in small vessel disease (sVD) 
patients.
Methods analyses used two prospective cohort studies 
of sVD: st. george’s cognition and neuroimaging 
in stroke (scans; n=121) and radboud University 
nijmegen Diffusion Tensor and Magnetic resonance 
cohort (rUn DMc; n=352). Multivariate cox regressions 
were used to predict dementia using baseline apathy and 
depression scores in both datasets. change in apathy 
and depression was used to predict dementia in a subset 
of 104 participants with longitudinal data from scans. 
all models were controlled for age, education and 
cognitive function.
results Baseline apathy scores predicted dementia in 
scans (hr 1.49, 95% ci 1.05 to 2.11, p=0.024) and 
rUn DMc (hr 1.05, 95% ci 1.01 to 1.09, p=0.007). 
increasing apathy was associated with dementia in 
scans (hr 1.53, 95% ci 1.08 to 2.17, p=0.017). in 
contrast, baseline depression and change in depression 
did not predict dementia in either dataset. including 
apathy in predictive models of dementia improved model 
fit.
Conclusions apathy, but not depression, may be a 
prodromal symptom of dementia in sVD, and may be 
useful in identifying at- risk individuals.
INTrOduCTION
Cerebral small vessel disease (SVD) is the leading 
vascular cause of dementia and plays a major role in 
cognitive decline and mortality.1 2 SVD affects the 
small vessels of the brain, leading to damage in the 
subcortical grey and white matter.1 The resulting 
clinical presentation includes cognitive and neuro-
psychiatric symptoms.1
Apathy is a reduction in goal- directed behaviour, 
which is a common neuropsychiatric symptom 
in SVD.3 Importantly, apathy is dissociable from 
depression,3 4 another symptom in SVD for 
which low mood is a predominant manifesta-
tion.5 Although there is some symptomatic overlap 
between the two,6 research using diffusion imaging 
reported that apathy, but not depression, was 
associated with white matter network damage in 
SVD.3 Many of the white matter pathways under-
lying apathy overlap with those related to cogni-
tive impairment, and accordingly apathy, rather 
than depression, has been associated with cognitive 
deficits in SVD.7 These results suggest that apathy 
and cognitive impairment are symptomatic of 
prodromal dementia in SVD.
We tested the hypothesis that apathy, but not 
depression, predicts all- cause dementia using 
two independent cohorts of SVD patients: the 
St. George’s Cognition and Neuroimaging Study 
(SCANS) and Radboud University Nijmegen Diffu-
sion Tensor and Magnetic Resonance Cohort (RUN 
DMC). We had three primary predictions: that base-
line apathy, but not depression, predicts dementia 
after controlling for SVD- related cognitive impair-
ment; that longitudinal changes in apathy, but not 
depression, would also predict dementia; and that 
the inclusion of apathy would improve dementia 
prediction models without apathy.
MeThOds
Participants
St. George’s Cognition and Neuroimaging in Stroke
Participants were recruited from stroke services 
at three UK hospitals covering a geographically 
contiguous region of South London. Included 
participants had a clinical lacunar stroke syndrome8 
with MRI evidence of a lacunar infarct, defined as a 
high- signal lesion on diffusion- weighted imaging or 
cavitated lacune on T1- weighted imaging of diam-
eter ≤1.5 cm, and confluent white matter hyperin-
tensities (WMH) of Fazekas grade ≥2.9
Exclusion criteria were: stroke mechanisms other 
than SVD, including cortical infarcts, cardioembo-
lism, intra/extracranial large artery stenosis >50%, 
or subcortical infarct diameter >1.5 cm; history of 
major neurologic or psychiatric condition excepting 
depression; non- fluent in English; unsuitable for 
MRI; or unable to give informed consent.
Baseline assessments were conducted a minimum 
of 3 months after the most recent stroke to reduce 
the influence of acute ischaemia on outcomes, with 
annual follow- up for up to 5 years. Participants 
provided written informed consent.
Radboud University Nijmegen Diffusion Tensor and 
Magnetic Resonance Cohort
Consecutive referrals to the Department of 
Neurology at Radboud University for symptoms 
of SVD between 2002 and 2006 were selected for 
possible participation.10 Included participants were 
between 50 and 85 years old and had evidence of 
cerebral SVD on neuroimaging, defined as lacunes 
or WMH.11 Individuals eligible because of a clinical 
lacunar stroke syndrome were included >6 months 
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after the event to minimise the effect of the acute infarct on 
outcomes.
Exclusion criteria included: dementia, assessed using the Diag-
nostic and Statistical Manual of Mental Disorders (DSM)- IV- TR 
criteria12; Parkinson(- ism); intracranial haemorrhage; life expec-
tancy <6 months; intracranial space- occupying lesion; disease 
interfering with cognitive testing or follow- up, including bipolar 
disorder and schizophrenia; current or recent use of acetylcho-
linesterase inhibitors, neuroleptic agents, levodopa or dopamine 
a(nta)gonists; WMH of non- vascular origin, such as multiple 
sclerosis; prominent visual or hearing impairment; language 
barrier and MRI contraindications or known claustrophobia. 
Participants provided written informed consent.
Apathy and depression
St. George’s Cognition and Neuroimaging in Stroke
Apathy and depression were assessed using the 30- item Geri-
atric Depression Scale (GDS).13 This scale can be separated into 
a 6- item measure of apathy, with the remaining items assessing 
depression.4 One memory- related question (Do you feel you 
have more problems with memory than most?) was excluded in 
the calculation of the depression scores as this may bias assess-
ments of dementia,14 leaving 23 items. The internal consistency 
of the apathy and depression subscales of the GDS, as measured 
by Cronbach's α, were adequate, (GDSapathy α=0.63 and GDSde-
pression α=0.90). The psychometric characteristics of these GDS 
subscales have been explored in greater detail elsewhere.4 14
Radboud University Nijmegen Diffusion Tensor and Magnetic 
Resonance Cohort
Apathy was assessed using the 18- item clinician- rated Apathy 
Evaluation Scale (AES).15 The AES was only administered at 
2011 and 2015, precluding an analysis of baseline AES scores. 
Furthermore, as data collection for RUN DMC is still ongoing, 
no data on progression to dementia were available beyond 2015, 
so only 2011 AES scores were analysed. Depression was assessed 
using the 20- item Center for Epidemiologic Studies Depression 
Scale (CESD),16 with two motivation- related items removed (felt 
that everything was an effort; could not get ‘going’). The internal 
consistency of the 18- item CESD (α=0.87) was not substantially 
different from the 20- item CESD (α=0.88).
Cognitive assessment
Both studies administered neuropsychological tasks sensitive to 
processing speed (PS). PS deficits are a manifestation of vascular 
cognitive impairment and are associated with pathological white 
matter changes in SVD.17 Raw task scores were converted into 
z- scores using normative values and averaged to produce a 
composite measure of PS. Tasks in SCANS included the Digit 
Symbol Substitution Test, Grooved Pegboard Test, and the Speed 
of Information Processing task from the Brain Injury Rehabilita-
tion Trust Memory and Information Processing Battery.18 Tasks 
in RUN DMC included the Paper- Pencil Memory Scanning Task 
and Letter Digit Substitution Task.10
All-cause dementia diagnosis
St. George’s Cognition and Neuroimaging in Stroke
Dementia was defined using the DSM-5 definition of major 
neurocognitive disorder.5 Participants were diagnosed with 
dementia if they met one of the following criteria: dementia was 
diagnosed in a memory clinic or equivalent clinical service; panel 
consensus between a neurologist and clinical neuropsycholo-
gist that the clinical picture met DSM-5 criteria for dementia 
after blind review of medical records and cognitive assessments 
or Mini Mental State Examination (MMSE) <24, indicative 
of cognitive impairment,19 and an Instrumental Activities of 
Daily Living (IADL) ≤7, indicating reduced capabilities in daily 
living.20
The date of dementia was defined as the date of the diagnosis. 
If this was unknown, and the diagnosis was based on review of 
medical records or cognitive performance, the midpoint date 
between the visit at which the diagnosis was established and the 
previous visit was used.
Radboud University Nijmegen Diffusion Tensor and Magnetic 
Resonance Cohort
Dementia was defined using DSM- IV- TR criteria,12 which is 
broadly synonymous with the DSM-5 definition of major neuro-
cognitive disorder,21 and was considered present if: dementia 
was diagnosed in a memory clinic or equivalent clinical service; 
panel consensus between a neurologist, clinical neuropsychol-
ogist and geriatrician that the clinical picture met DSM- IV- TR 
criteria for dementia after blind review of medical records and 
cognitive assessments; or MMSE <24 and IADL≤7.
The date of dementia was defined as the date clinical symptoms 
became compatible with the diagnosis. If this was unknown, the 
midpoint between the baseline visit and the date of the diagnosis 
was used, or failing this, the date of admission to a nursing home 
due to dementia.
statistical analysis
Statistical analyses were conducted using R 3.6.2 with the 
‘survival’ package 3.1–8.22 All tests were two tailed with α=0.05. 
Analyses were conducted identically for SCANS and RUN DMC 
unless otherwise specified.
Clinical data were compared in four contexts:
1. Between SCANS and RUN DMC, assessing differences be-
tween datasets.
2. Between individuals who developed dementia or not within 
both datasets.
3. Between individuals who attended more than one assessment 
or not in SCANS, to see if any variables biased longitudinal 
assessments.
4. Between individuals stratified using median WMH scores in 
RUN DMC, to see if any variables differ based on disease 
severity.
Continuous variables were compared using Welch’s t- tests if 
normally distributed and Mann- Whitney U tests if not. Categor-
ical or binary variables were compared using Pearson’s χ2.
To test the first hypothesis, which was that baseline apathy, 
but not depression, would predict dementia, multivariate Cox 
regression models were created with baseline apathy and depres-
sion scores, along with age, education, and PS as covariates 
(model 1). Event times were calculated from the first visit that 
apathy was assessed until the onset of dementia, death or the 
date of the most recent assessment.
To test the second hypothesis, which was that longitudinal 
change in apathy, but not depression, would predict dementia, 
we used a multivariate Cox model with all longitudinal obser-
vations in SCANS (model 2). Apathy and depression scores, as 
well as if the participant had developed dementia at that point, 
were allowed to vary between intervals. A participant- specific 
cluster variance was added as a term in the model to adjust for 
non- independent observations.
To test the third hypothesis, which was that the addition 
of baseline apathy scores would improve models predicting 
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Table 1 Characteristics of participants included for cross- sectional 
analysis in SCANS and RUN DMC
sCANs (n = 121) ruN dMC (n = 352)
P 
Age 70.0 (9.7) 69.1 (8.2) 0.12
Sex, female (%) 43 (35.5) 142 (40.3) 0.41
Education <0.001
  Low (%) 56 (46.7) 34 (9.7)
  Medium (%) 43 (35.8) 198 (56.2)
  High (%) 21 (17.5) 120 (34.1)
Hypertension (%) 112 (92.6) 283 (80.4) 0.003
Diabetes (%) 22 (18.2) 52 (14.8) 0.58
Hypercholesterolaemia (%) 104 (86.0) 175 (49.7) <0.001
Smoking 0.003
  Never (%) 48 (39.7) 103 (29.3)
  Ex (%) 49 (40.5) 205 (58.2)
  Current (%) 24 (19.8) 44 (12.5)
BMI, kg/m2 27.0 (4.9) 27.8 (4.5) 0.023
MMSE 27.5 (2.7) 28.0 (2.2) 0.10
IADL 7.4 (1.2) 7.7 (1.0) <0.001
BMI, body mass index; IADL, instrumental activities of daily living; MMSE, Mini 
Mental State Examination; RUN DMC, Radboud University Nijmegen Diffusion 
Tensor and Magnetic Resonance Cohort; SCANS, St. George's Cognition and 
Neuroimaging in Stroke.
dementia, we compared two nested models. The first model 
included age, education and PS as covariates. The second model 
included the same terms as the first, but also added apathy. This 
second model was compared with the first model using a likeli-
hood ratio test. A significant difference indicates that the second 
model explained more variance in outcomes than the first. We 
also calculated Akaike information criterion (AIC) scores for 
both models. The model with the lower AIC is the better fitting 
model.23
For all models, variance inflation factors for covariates <10, 
and proportionality of hazards verified by non- significant 
variable- level and model- level scaled Schoenfeld residual tests.22 
Depression scores were log- transformed in both datasets due to 
positive skew. Cases with missing data in SCANS were listwise 
excluded (model 1: n=3; model 2: n=2).
resulTs
study populations
St. George’s Cognition and Neuroimaging in Stroke
One hundred and tewnty- one participants were recruited at 
baseline, all of which were included in cross- sectional analyses. 
Of these 121, 18 completed only one assessment because of 
death (n=7), study withdrawal (n=6), relocation (n=1), lost 
to follow- up (n=2) or withdrawal from full neuropsycholog-
ical testing (n=2), leaving 104 participants for the longitudinal 
analysis.
Radboud University Nijmegen Diffusion Tensor and Magnetic 
Resonance Cohort
Five hundred and three participants were recruited to the 
baseline assessment in 2006. Of these 503, 398 were able to 
attend follow- up in 2011. Reasons for missing the assessment 
included death (n=49), illness (n=19), relocation (n=5), lack of 
time (n=30) or lost to follow- up (n=2). An additional 46 were 
excluded due to reaching an endpoint before the 2011 assess-
ment (n=15), or missing data (n=46), leaving 352 participants 
with complete data for the analysis. Due to our apathy measure 
not being administered in 2006, the 2011 follow- up will hence-
forth be referred to as the baseline for RUN DMC.
Participant characteristics
Participants in SCANS had a higher burden of vascular disease 
compared with those in RUN DMC, evidenced by greater 
proportions of hypertension and hypercholesterolaemia 
(table 1). Participants in SCANS also showed lower IADL scores, 
indicating more impairment in activities of daily living.
baseline characteristics of participants who developed 
dementia
Follow- up data on progression to dementia was available for all 
participants. In SCANS, 24 of 121 participants (19.8%) devel-
oped dementia, while in RUN DMC, 38 of 352 participants 
(10.8%) developed dementia. Median time- to- event was 4.99 
years (IQR=3.83–6.15) in SCANS and 3.33 (IQR=3.10–3.56) 
in RUN DMC. In both datasets, participants with dementia were 
characterised by higher apathy, but similar levels of depression 
at baseline (table 2).
longitudinal cohort characteristics in sCANs
In SCANS, 104 participants attended at least one follow- up 
assessment over the 5- year course of the study. Twenty individ-
uals in the longitudinal cohort developed dementia (19.2%). 
Individuals who only attended the baseline were older and more 
cognitively impaired, but did not differ with regard to apathy 
and depression scores or dementia prevalence (table 3). ΔGDSap-
athy=−0.44 per year, while ΔGDSdepression=−0.89 per year.
disease severity group characteristics in ruN dMC
RUN DMC participants with WMH measurements (n=331) 
were divided into two groups using median WMH values 
(table 4). The above median WMH group was characterised by 
higher apathy, cognitive impairment and dementia prevalence, 
but did not differ in depression.
Cox regression analyses
Univariate Cox regression models were run for individual unad-
justed covariates, followed by a multivariate model with all 
covariates (table 5). Model 1, which evaluated baseline apathy 
and depression scores in predicting dementia in both data-
sets, showed that higher apathy scores were associated with 
an increased dementia risk in SCANS, as were apathy scores 
in RUN DMC, after controlling for age, education and PS. In 
contrast, depression scores in both datasets were not associated 
with dementia in univariate or multivariate models.
To illustrate the impact of apathy and depression on dementia 
risk, model 1 was rerun using median apathy and depression 
scores. Covariate- adjusted Kaplan- Meier survival curves demon-
strated that higher apathy was associated with a greater dementia 
risk over time in SCANS and RUN DMC (figure 1A), while 
depression showed mixed results (figure 1B).
Results in model 1 were largely consistent for model 2, which 
analysed longitudinal apathy and depression in SCANS. Change 
in apathy, but not change in depression, was associated with 
greater dementia risk in the multivariate model. One important 
difference from the cross- sectional models was that change in 
apathy was not associated with dementia when assessed in a 
univariate model.
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Table 2 Baseline characteristics of participants who developed all- cause dementia
sCANs ruN dMC
dementia (n = 24) No dementia (n = 97) P dementia (n = 38) No dementia (n = 314) P
Age 72.1 (10.5) 69.5 (9.5) 0.189 78.5 (4.5) 68.0 (7.8) <0.001
Sex, female (%) 5 (20.8) 38 (39.2) 0.149 12 (31.6) 130 (41.4) 0.322
Education 0.043 0.002
Low (%) 12 (52.2) 44 (45.4) 9 (23.7) 25 (8.0)
Medium (%) 11 (47.8) 32 (33.0) 23 (60.5) 175 (55.7)
High (%) 0 (0.0) 21 (21.6) 6 (15.8) 114 (36.3)
BMI, kg/m2 25.6 (5.7) 27.3 (4.6) 0.032 26.6 (5.9) 28.0 (4.3) 0.218
Hypertension (%) 23 (95.8) 89 (91.8) 0.804 30 (78.9) 253 (80.6) 0.982
Diabetes (%) 7 (29.2) 15 (15.5) 0.207 8 (22.2) 44 (14.6) 0.342
Hypercholesterolaemia (%) 23 (95.8) 81 (83.5) 0.219 27 (75.0) 148 (49.2) 0.006
Smoking 0.777 0.331
Never (%) 9 (37.5) 39 (40.2) 8 (21.1) 95 (30.3)
Ex (%) 9 (37.5) 40 (41.2) 23 (60.5) 182 (58.0)
Current (%) 6 (25.0) 18 (18.6) 7 (18.4) 37 (11.8)
Apathy 3.6 (1.7) 2.8 (1.7) 0.047 35.6 (11.6) 26.6 (7.0) <0.001
Depression 6.4 (6.0) 5.5 (5.1) 0.527 13.8 (5.8) 14.4 (4.0) 0.326
MMSE 24.9 (3.8) 28.2 (1.8) <0.001 24.3 (3.5) 28.5 (1.4) <0.001
PS index −2.0 (0.4) −0.8 (0.8) <0.001 −1.9 (0.5) −1.1 (0.7) <0.001
IADL 6.4 (2.0) 7.7 (0.7) <0.001 6.2 (2.1) 7.9 (0.5) <0.001
BMI, body mass index; IADL, Instrumental Activities of Daily Living; MMSE, Mini Mental State Examination; PS, processing speed; RUN DMC, Radboud University Nijmegen 
Diffusion Tensor and Magnetic Resonance Cohort; SCANS, St. George's Cognition and Neuroimaging in Stroke.
Table 3 Characteristics of participants with longitudinal data in 
SCANS
Only baseline 
(n = 17)
longitudinal 
cohort (n = 104)
P 
Age 74.9 (8.0) 69.2 (9.8) 0.015
Sex, female (%) 7 (41.2) 36 (34.6) 0.802
Education 0.091
  Low (%) 12 (70.6) 44 (42.7)
  Medium (%) 4 (23.5) 39 (37.9)
  High (%) 1 (5.9) 20 (19.4)
Hypertension (%) 16 (94.1) 96 (92.3) 1.000
Diabetes (%) 5 (29.4) 17 (16.3) 0.339
Hypercholesterolaemia (%) 15 (88.2) 89 (85.6) 1.000
Smoking 0.436
  Never (%) 9 (52.9) 39 (37.5)
  Ex (%) 6 (35.3) 43 (41.3)
  Current (%) 2 (11.8) 22 (21.2)
BMI, kg/m2 27.7 (3.3) 26.9 (5.1) 0.327
Dementia 4 (23.5) 20 (19.2) 0.933
Apathy 3.0 (1.6) 2.9 (1.8) 0.982
Depression 4.9 (5.0) 5.8 (5.4) 0.500
MMSE 25.6 (3.1) 27.8 (2.5) <0.001
PS index −1.3 (1.0) −0.9 (0.9) 0.074
IADL 6.9 (1.7) 7.5 (1.1) 0.075
BMI, body mass index; IADL, Instrumental Activities of Daily Living; MMSE, Mini Mental 
State Examination; PS, processing speed; SCANS, St. George's Cognition and Neuroimaging 
in Stroke.
Table 4 Characteristics of participants in RUN DMC, stratified by 
median WMH scores
low severity 
(n = 166)
Moderate- high 
severity (n = 165) P
Age 65.5 (6.7) 72.6 (8.1) <0.001
Sex, female (%) 66 (39.8) 68 (41.2) 0.875
Education 0.009
Low (%) 9 (5.4) 21 (12.7)
Medium (%) 88 (53.0) 97 (58.8)
High (%) 69 (41.6) 47 (28.5)
Hypertension (%) 122 (73.5) 143 (86.7) 0.004
Diabetes (%) 20 (12.7) 28 (17.5) 0.305
Hypercholesterolaemia (%) 70 (44.6) 91 (56.9) 0.038
Smoking 0.029
Never (%) 53 (31.9) 42 (25.5)
Ex (%) 85 (51.2) 107 (64.8)
Current (%) 28 (16.9) 16 (9.7)
BMI, kg/m2 27.9 (4.4) 27.8 (4.8) 0.89
Dementia 5 (3.0) 28 (17.0) <0.001
Apathy 25.5 (6.4) 29.4 (9.3) <0.001
Depression 14.5 (3.6) 14.3 (4.7) 0.714
MMSE 28.6 (1.5) 27.6 (2.4) <0.001
PS index −1.1 (0.7) −1.4 (0.7) <0.001
IADL 7.9 (0.3) 7.5 (1.3) <0.001
BMI, body mass index; IADL, Instrumental Activities of Daily Living; MMSE, Mini 
Mental State Examination; PS, processing speed; RUN DMC, Radboud University 
Nijmegen Diffusion tensor and Magnetic resonance Cohort; WMH, White matter 
hyperintensity volume.
ruN dMC results do not depend on disease severity
Given that disease severity groups in RUN DMC differed on key 
variables (table 4), we reran model 1 with the median WMH 
grouping variable as a covariate. Results remained consistent, 
with apathy being associated with dementia, (HR 1.06, 95% CI 
1.02 to 1.10, p=0.002), but not depression, (HR 1.06, 95% CI 
0.47 to 2.41, p=0.89). Age remained associated with dementia, 
(HR 1.17, 95% CI 1.09 to 1.24, p<0.001), as did PS, (HR 0.29, 
95% CI 0.14 to 0.60, p<0.001). Education was not associated 
with dementia, (HR 0.63, 95% CI 0.34 to 1.15, p=0.13), nor 
was WMH group (HR 1.28, 95% CI 0.45 to 3.64, p=0.65).
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Table 5 Cox proportional hazards models with all- cause dementia as the outcome variable
sCANs ruN dMC
univariate Multivariate univariate Multivariate
hr (95% CI) P hr (95% CI) P hr (95% CI) P hr (95% CI)
Model 1 C=0.904 (0.022) C=0.914 (0.019)
  Apathy 1.30 (1.01 to 1.68) 0.041 1.49 (1.05 to 2.11) 0.024 1.09 (1.06 to 1.12) <0.001 1.05 (1.01 to 1.09) 0.007
  Depression 1.13 (0.70 to 1.85) 0.616 1.18 (0.59 to 2.37) 0.638 1.26 (0.89 to 1.77) 0.193 0.92 (0.64 to 1.31) 0.629
  Age 1.03 (0.99 to 1.09) 0.159 1.07 (1.00 to 1.14) 0.047 1.17 (1.12 to 1.23) <0.001 1.17 (1.11 to 1.24) <0.001
  Education 0.57 (0.30 to 1.07) 0.08 0.92 (0.42 to 2.03) 0.844 0.43 (0.26 to 0.71) 0.001 0.67 (0.39 to 1.17) 0.158
  PS 0.10 (0.04 to 0.22) <0.001 0.03 (0.01 to 0.12) <0.001 0.16 (0.09 to 0.27) <0.001 0.27 (0.14 to 0.54) <0.001
Model 2 C=0.937 (0.027)
  Apathy 1.11 (0.86 to 1.42) 0.436 1.53 (1.08 to 2.17) 0.017
  Depression 1.29 (0.67 to 2.46) 0.443 0.65 (0.10 to 4.38) 0.654
  Age 1.05 (0.97 to 1.14) 0.231 1.21 (1.02 to 1.45) 0.033
  Education 1.14 (0.71 to 1.82) 0.586 4.00 (1.50 to 10.70) 0.006
  PS 0.10 (0.04 to 0.23) <0.001 0.00 (0.00 to 0.03) <0.001
Raw depression scores were log- transformed due to positive skew in all analyses.
PS, processing speed; RUN DMC, Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort; SCANS, St. George's Cognition and Neuroimaging in Stroke.
Figure 1 cumulative dementia risk for participants stratified by median 
baseline apathy and depression scores. (a) Dementia risk for patients 
stratified on median apathy scores in scans (left) and run DMc (right); 
(B) dementia risk for patients stratified on median depression scores in 
scans (left) and run DMc (right). P values from cox regression results. 
aes, apathy evaluation scale; cesD, center for epidemiological studies 
Depression scale; DMc, Diffusion Tensor and Magnetic resonance cohort; 
gDs, geriatric Depression scale;
Apathy improves models predicting dementia
To evaluate whether the addition of apathy increased the utility 
of these models for predicting dementia, a model with age, 
education and PS as covariates was compared with a model with 
apathy, age, education and PS. Likelihood ratio tests revealed that 
the inclusion of apathy led to improved model fit in both SCANS 
(χ2=5.30, p=0.021) and RUN DMC (χ2=5.67, p=0.017). 
These models were also compared using the AIC. Models with 
apathy minimised showed lower AIC values than those without 
apathy in SCANS (AICno apathy=153.4, AICwith apathy=146.8) and 
RUN DMC (AICno apathy=332.0, AICwith apathy=327.5), indicating 
that models with apathy better fit the data.23
dIsCussION
We tested the hypothesis that apathy, but not depression, is asso-
ciated with dementia in patients with SVD. We found that higher 
baseline apathy, as well as increasing apathy over time, were 
associated with an increased dementia risk. In contrast, neither 
baseline depression or change in depression was associated 
with dementia. The relationship between apathy and dementia 
remained after controlling for other well- established risk factors 
including age, education and cognition.24 Finally, adding apathy 
to models predicting dementia improved model fit. These results 
suggest that apathy may be a prodromal symptom of dementia 
in patients with SVD.
Importantly, our hypotheses were investigated in two inde-
pendent cohorts of symptomatic patients with MRI- confirmed 
SVD. These cohorts differed in overall disease burden as well as 
apathy and depression assessments, but had identical definitions 
for radiological markers of SVD.11 Despite these differences, we 
found that apathy, but not depression, was consistently associ-
ated with dementia risk in both studies. This suggests that our 
findings are robust and reproducible, and may be generalisable 
across a broad spectrum of SVD severity. SCANS, by virtue of its 
inclusion criteria, had a higher burden of SVD pathology when 
compared with RUN DMC, reflected in a higher proportion of 
vascular risk factors and greater IADL impairment. This may 
explain why SCANS had nearly double the dementia prevalence 
compared with RUN DMC despite similar dementia criteria and 
follow- up durations.
Intriguingly, we found that longitudinal change in apathy was 
not associated with dementia in a univariate model, but became 
significant in a multivariate model. This is an example of positive 
confounding, whereby effect sizes are overestimated due to a 
confounding variable.25 This effect may stem from a variety of 
factors, but may indicate that change in apathy is only predic-
tive of dementia in a particular subgroup. Unfortunately, the 
sample size of the longitudinal cohort of SCANS was too small 
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to investigate this possibility (ie, interaction effects), and must 
therefore be explored in future research with larger cohorts.
Our results initially appear to diverge with findings from the 
Prevention of Dementia by Intensive Vascular Care trial, which 
showed that apathy and depression, assessed using the 15- item 
GDS, predicted incident dementia in community- dwelling indi-
viduals.14 The investigators, however, found that the associa-
tions between depression and dementia were largely driven by 
the GDS question assessing memory complaints. After removing 
that item from the calculation of depression scores, which we 
did a priori, this association became non- significant. Further-
more, the authors also found that an interaction between apathy 
and a history of stroke predicted dementia. This interaction may 
have been partially driven by patients with SVD with lacunar 
stroke, which was explored in our study. Our results may there-
fore contextualise their findings in individuals with SVD.
Our findings may clarify why there are inconsistent reports of 
associations between late- life depression or depressive symptoms 
and dementia risk.26 Clinical depression scales may also assess 
apathy, as evidenced by motivation- related questions on the 
GDS and CESD. These apathy items may be a factor underlying 
the relationship between depressive symptoms and dementia in 
the elderly. This is an important consideration for future studies 
that use scales to measure depression. In our study, removing 
these apathy items had minimal effects on internal consistency, 
suggesting that this may be a valid approach for assessing a more 
theoretically narrow depression construct.
The number of people living with dementia worldwide is 
projected to triple by 2050,27 making early diagnosis and inter-
vention increasingly important. Late- life cognitive functioning 
may be maintained by targeting modifiable factors such as cardio-
vascular risk, physical activity and diet.28 Our results support 
the notion that measuring apathy may be clinically useful as a 
non- invasive and inexpensive method for identifying patients 
at- risk for developing dementia.14 Additionally, our longitudinal 
findings suggest that continued monitoring of apathy may be a 
way to assess changes in dementia risk. Individuals identified as 
having high apathy, or increasing apathy over time, could be sent 
for a more detailed neurocognitive or neuropathological exam-
ination, or be selected for therapeutic interventions.
Examining relationships between apathy and dementia- related 
mortality is another important area for future research, given 
findings that apathy is associated with all- cause mortality.29 
These results, in conjunction with ours, suggests that apathy 
may be associated with an increased risk of dementia- related 
mortality. If this is the case, then apathy may signal for a more 
severe prognosis in vascular dementia patients.
Our work also suggests that another area for research lies 
in identifying mechanisms linking apathy to dementia onset. 
Recent neuroimaging work suggests that similar white matter 
networks underlie motivation and normal cognitive function 
in SVD.3 It is possible that vascular pathology that damages 
these networks30 leads to a prodromal form of dementia 
which presents with apathy and cognitive deficits. Over 
time, SVD- related pathology increases, which is paralleled by 
increasing cognitive and motivational impairment,31 32 eventu-
ally becoming severe enough to meet criteria for a dementia 
state. This implies that apathy is not a risk factor for dementia 
per se, but rather an early symptom of white matter network 
damage. Indeed, recent theoretical work proposed that certain 
symptoms of apathy are synonymous with defined cognitive 
deficits.33 If this is the case, then apathy may manifest early 
as a reduction in attention towards reward stimuli, then later, 
as an inability to learn or remember rewarding behaviours. 
This would be consistent with initial executive deficits that 
are followed by declining episodic memory, which may be a 
cognitive phenotype of SVD patients that develop vascular or 
mixed dementia.32 34
There are some limitations to our study. Full follow- up data for 
dementia are not available in RUN DMC, precluding the longi-
tudinal analysis of apathy conducted in SCANS. Another limita-
tion was the use of clinical scales to assess apathy and depression. 
Although a structured clinical interview may have yielded a more 
accurate measure of neuropsychiatric symptomatology, this was 
not feasible due to time constraints. A related limitation was our 
use of the MMSE and IADL in detecting patients with dementia. 
Although the cut scores used have been determined empirically, 
many of the studies assessing this have used older DSM definitions. 
Further work will be needed to evaluate the accuracy of the MMSE 
and IADL at detecting major neurocognitive disorder using DSM-5 
criteria.
Participant drop- out was a concern in both studies. It is possible 
that individuals with higher baseline apathy were less likely to 
attend follow- ups, potentially confounding results. While this was 
not the case in SCANS, this could not be confirmed in RUN DMC. 
This led to smaller sample sizes and fewer events in both popula-
tions, precluding comprehensive subgroup or interaction testing as 
mentioned earlier.
Finally, the time scale that participants were assessed on was 
relatively short, with data for both studies ending within 5 years. 
Preliminary evidence suggests that the relationships between 
apathy, depression and dementia may change over longer periods,14 
and our results need be replicated over a longer duration.
Our work has shown that apathy, but not depression, predicted 
all- cause dementia in SVD, supporting the hypothesis that apathy 
is a prodromal symptom of dementia. This shows that distin-
guishing between these symptoms has implications for clinical 
practice and research. It also suggests that apathy may be useful in 
predictive models of dementia, and that the assessment of apathy 
over time may be informative for dementia diagnosis. Finally, 
it provides a basis for future studies attempting to understand 
mechanisms linking apathy, vascular cognitive impairment and 
dementia.
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